SQZB
Sqz Biotechnologies Company
A clinical-stage biotechnology company that builds a cell-engineering platform called Cell Squeeze®, which physically squeezes cells through a narrow microfluidic chip to open temporary pores and let therapeutic materials slip inside. It was founded in 2013 as a spin-out from MIT by PhD student Armon Sharei and professors Klavs Jensen and Robert Langer. The name comes from a happy accident: the team first tried a "microfluidic gun" to shoot molecules into cells, but the cells were too squishy — the squeezing itself proved the breakthrough.
CUSIP: 78472W104HealthcareUS1 holder
Recent Activity
2023Q3
1 sell
-1.05M shares
Maverick CapitalEXIT
-1.05M shares
2023Q2
1 sell
-1.5K shares(-0.1%)
Maverick CapitalTRIM
-1.5K shares(-0.1%)
2023Q1
1 sell
-16.4K shares(-1.5%)
Maverick CapitalTRIM
-16.4K shares(-1.5%)
Loading more activity...